Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus". (Updates from 10:45 a.m. ET with closing information.)
NEW YORK (TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk on the Street" Wednesday.
A new cholesterol drug from Regeneron Pharmaceuticals (REGN) had very positive phase III results and Cramer said it's putting Merck's (MRK) Zetia drug to shame. REGN jumped 6% to $17.22.
BMO initiated Kroger (KR) with a neutral rating. Cramer said he prefers Whole Foods Market (WFM). KR rose 1% to $41.87. "Goldman Sachs blesses" American Tower (AMT) by reiterating it as a buy, Cramer said, adding that the last thing we heard about the company involved accounting issues. AMT was 3.2% higher at $77.12. Deutsche Bank raised its price target on Cheniere Energy (LNG). Even though the stock has quadrupled in value, it appears to still have upside, according to Cramer. LNG was up 3.5% on the day to $38.17. Stanley Black & Decker (SWK) provided dismal guidance and had poor margins, said Cramer. "This is a disaster." SWK plummeted 14.3% to $76.75. Conversely, Abbott Laboratories (ABT) beat earnings estimates and raised its dividend. Cramer thinks CEO Miles White is going great things and likes the dividend. ABT jumped 6.5% to $35.90. To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here. -- Written by Bret Kenwell in Petoskey, Mich. Follow @BretKenwell